SE428127B - Forfarande for framstellning av 2-hydroximetyl-3-hydroxi-6-(1-hydroxi-2-t-butylaminoetyl)-pyridin - Google Patents

Forfarande for framstellning av 2-hydroximetyl-3-hydroxi-6-(1-hydroxi-2-t-butylaminoetyl)-pyridin

Info

Publication number
SE428127B
SE428127B SE7609497A SE7609497A SE428127B SE 428127 B SE428127 B SE 428127B SE 7609497 A SE7609497 A SE 7609497A SE 7609497 A SE7609497 A SE 7609497A SE 428127 B SE428127 B SE 428127B
Authority
SE
Sweden
Prior art keywords
hydroxy
hydroximethyl
butylaminoethyl
pyridine
preparing
Prior art date
Application number
SE7609497A
Other languages
English (en)
Swedish (sv)
Other versions
SE7609497L (sv
Inventor
R D Carroll
J R Tretter
B S Moore
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of SE7609497L publication Critical patent/SE7609497L/xx
Publication of SE428127B publication Critical patent/SE428127B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/65—One oxygen atom attached in position 3 or 5

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SE7609497A 1975-10-03 1976-08-26 Forfarande for framstellning av 2-hydroximetyl-3-hydroxi-6-(1-hydroxi-2-t-butylaminoetyl)-pyridin SE428127B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/619,302 US4011231A (en) 1975-10-03 1975-10-03 2-Phenyl-6-(1-hydroxy-2-t-butylaminoethyl)-4H-pyrido[3,2-d]-1,3-dioxin maleate and its use as an intermediate

Publications (2)

Publication Number Publication Date
SE7609497L SE7609497L (sv) 1977-04-04
SE428127B true SE428127B (sv) 1983-06-06

Family

ID=24481329

Family Applications (2)

Application Number Title Priority Date Filing Date
SE7609497A SE428127B (sv) 1975-10-03 1976-08-26 Forfarande for framstellning av 2-hydroximetyl-3-hydroxi-6-(1-hydroxi-2-t-butylaminoetyl)-pyridin
SE8003311A SE437159B (sv) 1975-10-03 1980-04-30 Maleinsyrasalt av 2-fenyl-6-(1-hydroxi-2-t-butylaminoetyl)-4h-pyrido(3,2-d)-1,3-dioxin for anvendning sasom intermediat vid framstellning av 2-hydroximetyl-3-hydroxi-6-(1-hydroxi-2-t-butylaminoetyl)-pyridin

Family Applications After (1)

Application Number Title Priority Date Filing Date
SE8003311A SE437159B (sv) 1975-10-03 1980-04-30 Maleinsyrasalt av 2-fenyl-6-(1-hydroxi-2-t-butylaminoetyl)-4h-pyrido(3,2-d)-1,3-dioxin for anvendning sasom intermediat vid framstellning av 2-hydroximetyl-3-hydroxi-6-(1-hydroxi-2-t-butylaminoetyl)-pyridin

Country Status (30)

Country Link
US (1) US4011231A (ja)
JP (1) JPS5246081A (ja)
AR (1) AR213180A1 (ja)
AT (1) AT353789B (ja)
BE (1) BE846471A (ja)
BG (1) BG27544A3 (ja)
CA (1) CA1059518A (ja)
CH (1) CH616424A5 (ja)
CS (2) CS205042B2 (ja)
DD (2) DD133672A5 (ja)
DE (1) DE2640123C3 (ja)
DK (1) DK147049C (ja)
ES (2) ES451746A1 (ja)
FI (1) FI64354C (ja)
FR (1) FR2326191A1 (ja)
GB (1) GB1510075A (ja)
GR (1) GR61628B (ja)
HU (2) HU177493B (ja)
IE (1) IE43503B1 (ja)
LU (1) LU75898A1 (ja)
NL (1) NL164274C (ja)
NO (1) NO147027C (ja)
PH (1) PH14511A (ja)
PL (1) PL106863B1 (ja)
PT (1) PT65619B (ja)
RO (1) RO69886A (ja)
SE (2) SE428127B (ja)
SU (2) SU673168A3 (ja)
YU (1) YU39545B (ja)
ZA (1) ZA765253B (ja)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4477671A (en) * 1981-02-09 1984-10-16 Pfizer Inc. 3-Acetoxy or benzyloxy-2-acetoxymethyl-6-[1-acetoxy-2-(N-tert-butylacetamido)ethyl]pyridine intermediates
US4632992A (en) * 1981-02-09 1986-12-30 Pfizer Inc. Intermediates for preparing pirbuterol and analogs
US5395939A (en) * 1993-11-30 1995-03-07 North Carolina State University Method of making asymmetric de ring intermediates for the synthesis of camptothecin and camptothecin analogs

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3250778A (en) * 1962-11-29 1966-05-10 Hoffmann La Roche Intermediates for and synthesis of vitamin b and related compounds
US3700681A (en) * 1971-02-16 1972-10-24 Pfizer 2-hydroxymethyl-3-hydroxy-6-(1-hydroxy-2-aminoethyl)pyridines

Also Published As

Publication number Publication date
FI64354B (fi) 1983-07-29
US4011231A (en) 1977-03-08
NL7610683A (nl) 1977-04-05
NL164274C (nl) 1980-12-15
CA1059518A (en) 1979-07-31
DK147049B (da) 1984-03-26
NO763307L (ja) 1977-04-05
AT353789B (de) 1979-12-10
DE2640123B2 (de) 1980-01-31
FI64354C (fi) 1983-11-10
IE43503B1 (en) 1981-03-11
IE43503L (en) 1977-04-03
FR2326191B1 (ja) 1978-11-17
SE7609497L (sv) 1977-04-04
PH14511A (en) 1981-08-24
DD133672A5 (de) 1979-01-17
ZA765253B (en) 1977-08-31
RO69886A (ro) 1981-09-24
PT65619A (en) 1976-10-01
HU177493B (en) 1981-10-28
PL106863B1 (pl) 1980-01-31
SU673168A3 (ru) 1979-07-05
HU172998B (hu) 1979-01-28
AU1788376A (en) 1978-03-16
YU39545B (en) 1984-12-31
FR2326191A1 (fr) 1977-04-29
NL164274B (nl) 1980-07-15
DD129325A5 (de) 1978-01-11
CH616424A5 (ja) 1980-03-31
CS205042B2 (en) 1981-04-30
DK434176A (da) 1977-04-04
ATA692376A (de) 1979-05-15
LU75898A1 (ja) 1977-05-11
DE2640123A1 (de) 1977-04-07
BE846471A (fr) 1977-03-23
SE8003311L (sv) 1980-04-30
GR61628B (en) 1978-12-04
NO147027C (no) 1983-01-19
YU216576A (en) 1982-06-30
DK147049C (da) 1984-10-01
NO147027B (no) 1982-10-11
CS205041B2 (en) 1981-04-30
ES457257A1 (es) 1978-02-01
SU725562A3 (ru) 1980-03-30
ES451746A1 (es) 1977-08-16
AR213180A1 (es) 1978-12-29
GB1510075A (en) 1978-05-10
FI762693A (ja) 1977-04-04
JPS5519210B2 (ja) 1980-05-24
SE437159B (sv) 1985-02-11
BG27544A3 (en) 1979-11-12
JPS5246081A (en) 1977-04-12
DE2640123C3 (de) 1980-09-25
PT65619B (en) 1978-04-05

Similar Documents

Publication Publication Date Title
SE430335B (sv) Analogiforfarande for framstellning av pyridinyl-pyridinoner
SE429970B (sv) Forfarande for framstellning av glukopyranosido-1,6-mannit
SE434049B (sv) Forfarande for framstellning av 1,4-dihydropyridinderivat
SE431456B (sv) Analogiforfarande for framstellning av kondenserade kinazolonderivat
SE421698B (sv) Forfarande for framstellning av 4,5,6,7-tetrahydro-tieno (2,3-c) pyridinderivat
SE434394B (sv) Analogiforfarande for framstellning av kinolonalkansyraderivat
SE403380B (sv) Forfarande for framstellning av 17alfa-estrar-21-halogenpregnaner
SE431872B (sv) Analogiforfarande for framstellning av derivat av 4-pyrimidon
SE428684B (sv) Analogiforfarande for framstellning av substituerade (3-lagalkylamino-2-hydroxi-propoxi)pyridiner
SE421795B (sv) Forfarande for framstellning av 4,5,6,7-tetrahydro-tieno(3,2-c)pyridin-derivat
SE433745B (sv) Forfarande for framstellning av tetrahydroisokinolinderivat
DK360576A (da) Fremgangsmade til fremstilling af pyridinderivater
SE428685B (sv) Analogiforfarande for framstellning av cyanosubstituerade (3-lagalkylamino-2-acyl-0-propoxi)pyridiner
SE7613973L (sv) Forfarande for framstellning av pappersmassa
SE7613768L (sv) Forfarande for framstellning av penicillinestrar
SE428296B (sv) Analogiforfarande for framstellning av substituerade difonylsulfider
SE423390B (sv) Foerfarande foer framstaellning av eburnameninderivat
SE423902B (sv) Forfarande for framstellning av purinderivat
SE7606890L (sv) Forfarande for framstellning av polyacetovinyldispersioner
SE421622B (sv) Forfarande for framstellning av 4,5,6,7-tetrahydro-tieno(3,2-c)-pyridinderivat
SE428127B (sv) Forfarande for framstellning av 2-hydroximetyl-3-hydroxi-6-(1-hydroxi-2-t-butylaminoetyl)-pyridin
SE418858B (sv) Forfarande for framstellning av 2-hydroximetyl-3-hydroxi-6-(1-hydroxi-2-t-butylaminoetyl)-pyridin
SE420093B (sv) Forfarande for framstellning av 5-fenyl-2-furamidoximer
SE7609130L (sv) Forfarande for framstellning av tradlacksdispersioner
SE428689B (sv) Forfarande for framstellning av aroyl-fenylnaftalenforeningar

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 7609497-8

Format of ref document f/p: F